Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis

Clinical Cancer Research

Volumn 10, Issue 13, 2004, Pages 4517-4526

  Yoon, Wan Hee ^a,d   Jung, Yeon Joo ^a   Kim, Tae Dong ^a   Li, Ge ^a   Park, Byoung Jeon ^a   Kim, Ji Yeon ^a   Lee, Young Chul ^a   Kim, Jin Man ^a   Park, Jong Il ^a   Park, Hae Duck ^a   No, Zae Sung ^b   Lim, Kyu ^a   Hwang, Byung Doo ^a   Kim, Young S ^c  

^a Chungnam National University College of Medicine   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; APROTININ; GABEXATE MESILATE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL MOTILITY; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; CORNEA; CORNEA NEOVASCULARIZATION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER METASTASIS; METASTASIS; PRIORITY JOURNAL; RABBIT; TUMOR CELL LINE;

ANIMALS; CAPILLARIES; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; FEMALE; GABEXATE; GELS; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; LIVER; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; RABBITS; SERINE PROTEINASE INHIBITORS; TEMPERATURE; TIME FACTORS; UMBILICAL VEINS; URINARY PLASMINOGEN ACTIVATOR;

EID: 3042817479     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0084     Document Type: Article

References (47)

1. Toribara NW, Kim YS. Premalignancy and malignancy of the colon. In: Sleisenger M, Fordtran J, editors. Gastrointestinal disease. Philadelphia: W. B. Saunders; 1992. p. 1-12.
2. Cohen AM, Minsky BD, Friedman MA. Rectal cancer. In: DeVita V, Hellman S, Rosenberg S, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott; 1993. p. 978-1005.
3. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991;51:5045-59.
4. Lukashev ME, Werb Z. ECM signaling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 1998;8:437-41.
5. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994;79:185-8.
6. Gottesman M. The role of proteases in cancer. Semin Cancer Biol 1990;1:97-160.
7. Dahiya R, Yoon W-H, Boyle B, et al. Biochemical, cytogenetic and morphological characteristics of human primary and metastatic prostate cancer cell lines. Biochem Int 1992;27:567-77.
8. Dano K, Andreasen PA, Grondahl-Hansen J, et al. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985;44:139-266.
9. Sappino AP, Busso N, Belin D, Vassalli JD. Increase of urokinase type plasminogen activator gene expression in human lung and breast carcinomas. Cancer Res 1987;47:4043-6.
10. Stetler-Stevenson WG. Progelatinase A activation during tumor cell invasion. Invasion Metastasis 1994-95;14:259-68.
11. Watson SA, Morris TM, Robinson G, et al. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res 1995;55:3629-33.
12. Naito K, Kanbayashi N, Nakajima S, et al. Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor. Int J Cancer 1994;58:730-5.
13. Albini A, Melchiori A, Santi L, et al. Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst (Bethesda) 1991;83:775-9.
14. Alvarez OA, Carmichael DF, DeClerck YA. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst (Bethesda) 1990;82:589-95.
15. DeClerck YA, Yean TD, Chan D, Shimada H, Langley KE. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res 1992;51:2151-7.
16. Schechte W, Brattain M, Boyd D. Invasion of extracellular matrix by cultured colon cancer cells: dependence on urokinase receptor display. Cancer Commun 1990;2:173-9.
17. Reich R, Thompson EW, Iwamoto Y, et al. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 1988;48:3307-12.
18. Ossowski L, Reich E. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 1983;35:611-9.
19. Escheicher A, Wohlwend A, Belin D, Vassalli JD. Characterization of the cellular binding site for the urokinase type plasminogen activator. J Biol Chem 1989;264:1180-9.
20. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinase-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993;157:351-8.
21. Anand-Apte B, Pepper MS, Voest E, et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Investig Ophthalmol Vis Sci 1997;38:817-23.
22. Benelli R, Adatia R, Ensoli B, et al. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Oncol Res 1994;6:251-7.
23. Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998;95:365-77.
24. Nguyen M, Arkell J, Jackson CJ. Thrombin rapidly and efficiently activates gelatinase A in human microvascular endothelial cells via a mechanism independent of activated MTRI matrix metalloproteinase. Lab Investig 1999;79:467-75.
25. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, et al. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-I cascade enhances tumor cell invasion. J Biol Chem 1999;274:13066-76.
26. Hahn-Dantona E, Ramos-DeSimone N, Sipley J, et al. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Ann NY Acad Sci 1999;878:372-87.
27. Tamura Y, Hirado M, Okamura K, Minato Y, Fujii S. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1F and C1 esterase. Biochim Biophys Acta 1977;484:417-22.
28. Ohno H, Kosaki G, Kambayashi J, Imaoka S, Hirata F. FOY: [Ethyl p-(6-guanidinohexanoyloxy)benzoate] methanesulfonate as a serine proteinase inhibitor. I. Inhibition of thrombin and factor Xa in vitro. Thromb Res 1980;19:579-88.
29. Jaffe EA, Nachman R, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Investig 1973;52:2745-56.
30. Bae D-G, Gho Y-S, Yoon W-H, Chae C-B. Arginine-rich antivascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis. J Biol Chem 2000;275:13588-96.
31. Yoon W-H, Park H-D, Lim K, Hwang B-D. Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells. Biochem Biophys Res Commun 1996;222:694-9.
32. Passaniti A, Taylor RM, Pili R, et al. A simple, quantitative method of assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and fibroblast growth factor. Lab Investig 1992;67:519-28.
33. Drabkin DL, Austin JH. Spectrophotometric constants for common hemoglobin derivatives in human, dog, and rabbit blood. J Biol Chem 1932;98:719.
34. Stetler-Stevenson WG. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Investig 1999;103:1237-41.
35. Itoh T, Tanioka M, Yoshida H, et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998;58:1048-51.
36. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001;21:1104-17.
37. Sledge GW, Qulali M, Goulet R, Bone EA, Fife R. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst (Bethesda) 1995;87:1546-50.
38. Chirivi RGS, Garofalo A, Crimmin MJ, et al. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 1994;58:460-4.
39. Jankun J, Keck RW, Skrzypczak-Jankun E, Swiercz R. Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficiency mice. Cancer Res 1997;57:559-63.
40. Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RM. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 1994;54:4726-8.
41. Davis B, Brown PD, East N, Crimmin MJ, Balkwill FR. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 1993;53:2087-91.
42. DeClerck YA, Perez N, Shimada H, et al. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992;52:701-8.
43. Folkman J, Klagbrun M. Angiogenic factors. Science (Wash DC) 1987;235:442-7.
44. Moses MA, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science (Wash DC) 1990;248:1408-10.
45. D'Errico A, Garbisa S, Liotta LA, et al. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol 1991;4:239-46.
46. Desrivieres S, Lu H, Peyri N, et al. Activation of the 92 kDa type IV collagenase by tissue kallikrein. J Cell Physiol 1993;157:587-93.
47. Curran S, Murraym GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000;36:1621-30.